Imagion Biosystems Limited
Imagion Biosystems Limited (IBXXF) Stock Overview
Explore Imagion Biosystems Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.5M
P/E Ratio
-1.37
EPS (TTM)
$-0.01
ROE
1.43%
IBXXF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Imagion Biosystems Limited (IBXXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.37 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.